DOI QR코드

DOI QR Code

Digestion Pattern of Antihypertensive Angiotensin I-Converting Enzyme Inhibitory Peptides from Saccharomyces cerevisiae in a Successive Simulated Gastricintestinal Bioreactor

  • Jang, Jeong-Hoon (Department of Life Science and Genetic Engineering, Paichai University) ;
  • Jeong, Seung-Chan (Department of Life Science and Genetic Engineering, Paichai University) ;
  • Lee, Jung-Kee (Department of Life Science and Genetic Engineering, Paichai University) ;
  • Lee, Jong-Soo (Department of Life Science and Genetic Engineering, Paichai University)
  • Received : 2010.09.30
  • Accepted : 2010.10.27
  • Published : 2011.03.31

Abstract

A cell-free extract of Saccharomyces cerevisiae containing the angiotensin I-converting enzyme (ACE) inhibitory peptide was treated in a successive simulated gastric-intestinal bioreactor (step 1: amylase digestion, step 2: gastric fluid digestion, step 3: intestinal fluid digestion) to illustrate the absorption pattern of antihypertensive ACE inhibitory peptide, and the ACE inhibitory activities of each step were determined. Total ACE inhibitory activities of step 1, step 2, and step 3 were 55.96%, 80.09%, and 76.77%, respectively. The peptide sequence of each steps was analyzed by MS/MS spectrophotometry. Eleven kinds of representative peptide sequences were conserved in each step, and representative new peptides including RLPTESVPEPK were identified in step 3.

Keywords

References

  1. Fujita H, Yokoyama K, Yoshikawa M. Classification and antihypertensive activity of angiotensin I-converting enzyme inhibitory peptides derived from food proteins. J Food Sci 2000;65:564-9. https://doi.org/10.1111/j.1365-2621.2000.tb16049.x
  2. Folkow B, Johansson B, Mellander S. The comparative effects of angiotensin and noradrenaline on consecutive vascular sections. Acta Physiol Scand 1961;53:99-104. https://doi.org/10.1111/j.1748-1716.1961.tb02267.x
  3. Ondetti MA, Cushman DW. Enzymes of the rennin-angiotensin system and their inhibitors. Annu Rev Biochem 1982;51:283-308. https://doi.org/10.1146/annurev.bi.51.070182.001435
  4. Ondetti MA, Rubin B, Cushman DW. Design of specific inhibitors of angiotensin converting enzyme: new class of orally active antihypertensive agent. Science 1977;196:441-4. https://doi.org/10.1126/science.191908
  5. Koo KC, Lee DH, Kim JH, Yu HE, Park JS, Lee JS. Production and characterization of antihypertensive angiotensin Iconverting enzyme inhibitor from Pholiota adipose. J Microbiol Biotechnol 2006;16:757-63.
  6. Kim JH, Lee DH, Jeong SC, Chung KS, Lee JS. Characterization of antihypertensive angiotensin I-converting enzyme inhibitor from Saccharomyces cerevisiae. J Microbiol Biotechnol 2004;14:1318-23.
  7. Test solutions, United States Pharmacopeia 28/National Formulary 23, 2005, USP-NF [Internet]. Rockville: United States Pharmacoprial Convention [cited 2005 Feb 14]. Available from: http://www.usp.org.
  8. Cushman DW, Cheung HS. Spectrophotometric assay and properties of angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol 1971;20:1637-48. https://doi.org/10.1016/0006-2952(71)90292-9
  9. Bae EA, Han MJ, Song MJ, Kim DH. Purification of rotavirus infection-inhibitory protein from Bifidobacterium breve K-110. J Microbiol Biotechnol 2002;12:553-6.
  10. Walker JM. Basic protein and peptide protocols. Totowa: Humana Press; 1994.

Cited by

  1. Recent Research in Antihypertensive Activity of Food Protein-derived Hydrolyzates and Peptides vol.56, pp.5, 2016, https://doi.org/10.1080/10408398.2012.724478